

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive thymic T cell selection (GO:0045059) | 9.08363526 |
| 2 | positive T cell selection (GO:0043368) | 8.58590493 |
| 3 | negative T cell selection (GO:0043383) | 8.47309614 |
| 4 | cytidine deamination (GO:0009972) | 8.25264941 |
| 5 | cytidine metabolic process (GO:0046087) | 8.25264941 |
| 6 | cytidine catabolic process (GO:0006216) | 8.25264941 |
| 7 | negative thymic T cell selection (GO:0045060) | 8.03217700 |
| 8 | thymic T cell selection (GO:0045061) | 7.85838648 |
| 9 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.54595770 |
| 10 | T cell selection (GO:0045058) | 7.37277047 |
| 11 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.02879893 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.02668436 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.70197114 |
| 14 | leukocyte aggregation (GO:0070486) | 6.67971296 |
| 15 | DNA deamination (GO:0045006) | 6.61579406 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.41030082 |
| 17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.36116516 |
| 18 | negative regulation of cell killing (GO:0031342) | 6.24024944 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.24024944 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 6.09320130 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.04941897 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.04941897 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 5.64795045 |
| 24 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.64164223 |
| 25 | T cell receptor signaling pathway (GO:0050852) | 5.40525953 |
| 26 | response to interleukin-15 (GO:0070672) | 5.29848641 |
| 27 | regulation of T cell tolerance induction (GO:0002664) | 5.28621124 |
| 28 | T cell migration (GO:0072678) | 5.24529759 |
| 29 | interferon-gamma production (GO:0032609) | 5.04616726 |
| 30 | cellular response to interleukin-15 (GO:0071350) | 5.03857495 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.99056712 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.86873532 |
| 33 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.85799940 |
| 34 | T cell costimulation (GO:0031295) | 4.70485380 |
| 35 | lymphocyte costimulation (GO:0031294) | 4.60676779 |
| 36 | negative regulation by host of viral transcription (GO:0043922) | 4.58150269 |
| 37 | positive regulation of interleukin-2 production (GO:0032743) | 4.57941682 |
| 38 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.55541866 |
| 39 | activated T cell proliferation (GO:0050798) | 4.55237512 |
| 40 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.47499229 |
| 41 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.33054541 |
| 42 | regulation of regulatory T cell differentiation (GO:0045589) | 4.30598297 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.30481507 |
| 44 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 4.30233179 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 4.26847533 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.23926245 |
| 47 | positive regulation of interleukin-4 production (GO:0032753) | 4.15177388 |
| 48 | regulation of interleukin-1 beta secretion (GO:0050706) | 4.10728132 |
| 49 | positive regulation of interleukin-1 secretion (GO:0050716) | 4.05410938 |
| 50 | negative regulation of viral genome replication (GO:0045071) | 4.04748577 |
| 51 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.04139758 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.01914664 |
| 53 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.00902345 |
| 54 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.98949519 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 3.94932978 |
| 56 | eosinophil chemotaxis (GO:0048245) | 3.93558208 |
| 57 | lymphocyte chemotaxis (GO:0048247) | 3.92654822 |
| 58 | positive regulation of T cell differentiation (GO:0045582) | 3.77651032 |
| 59 | positive regulation of humoral immune response (GO:0002922) | 3.77060699 |
| 60 | regulation of interleukin-13 production (GO:0032656) | 3.73696302 |
| 61 | regulation of interleukin-4 production (GO:0032673) | 3.73694862 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.69505839 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.69505839 |
| 64 | negative regulation of T cell apoptotic process (GO:0070233) | 3.66183709 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.66182275 |
| 66 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.63847085 |
| 67 | response to type I interferon (GO:0034340) | 3.63805884 |
| 68 | regulation of interleukin-1 secretion (GO:0050704) | 3.63389520 |
| 69 | positive regulation of defense response to virus by host (GO:0002230) | 3.59817537 |
| 70 | positive regulation of isotype switching (GO:0045830) | 3.58935024 |
| 71 | desmosome organization (GO:0002934) | 3.56803218 |
| 72 | T cell differentiation (GO:0030217) | 3.52509082 |
| 73 | eosinophil migration (GO:0072677) | 3.52434213 |
| 74 | regulation of interleukin-2 production (GO:0032663) | 3.52177587 |
| 75 | detection of bacterium (GO:0016045) | 3.51101272 |
| 76 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51017875 |
| 77 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.49604759 |
| 78 | alpha-beta T cell differentiation (GO:0046632) | 3.48432031 |
| 79 | tolerance induction (GO:0002507) | 3.46425458 |
| 80 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.45165886 |
| 81 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.44557458 |
| 82 | omega-hydroxylase P450 pathway (GO:0097267) | 3.42161659 |
| 83 | positive regulation of lymphocyte migration (GO:2000403) | 3.40881294 |
| 84 | positive regulation of DNA recombination (GO:0045911) | 3.40693149 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40146575 |
| 86 | alpha-beta T cell activation (GO:0046631) | 3.38647141 |
| 87 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.38295896 |
| 88 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.36524978 |
| 89 | mast cell activation (GO:0045576) | 3.36482569 |
| 90 | leukocyte cell-cell adhesion (GO:0007159) | 3.35573813 |
| 91 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.32800278 |
| 92 | regulation of defense response to virus by virus (GO:0050690) | 3.32618860 |
| 93 | regulation of T cell differentiation (GO:0045580) | 3.32015302 |
| 94 | positive regulation of T cell cytokine production (GO:0002726) | 3.30800465 |
| 95 | negative regulation of viral transcription (GO:0032897) | 3.28838989 |
| 96 | lymphocyte migration (GO:0072676) | 3.26504008 |
| 97 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.25674362 |
| 98 | positive regulation of lymphocyte differentiation (GO:0045621) | 3.24243425 |
| 99 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.23989338 |
| 100 | positive regulation of T cell activation (GO:0050870) | 3.22378031 |
| 101 | positive regulation of macrophage differentiation (GO:0045651) | 3.21462087 |
| 102 | granulocyte activation (GO:0036230) | 3.21271905 |
| 103 | positive regulation of B cell mediated immunity (GO:0002714) | 3.20523139 |
| 104 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.20523139 |
| 105 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.19304769 |
| 106 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.18373066 |
| 107 | T cell activation (GO:0042110) | 3.18328372 |
| 108 | regulation of isotype switching (GO:0045191) | 3.17715786 |
| 109 | chemokine-mediated signaling pathway (GO:0070098) | 3.17584314 |
| 110 | response to interferon-beta (GO:0035456) | 3.17254829 |
| 111 | regulation of cell killing (GO:0031341) | 3.16516718 |
| 112 | heterotypic cell-cell adhesion (GO:0034113) | 3.16394952 |
| 113 | regulation of viral genome replication (GO:0045069) | 3.15656322 |
| 114 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13135530 |
| 115 | regulation of alpha-beta T cell activation (GO:0046634) | 3.12813513 |
| 116 | lymph node development (GO:0048535) | 3.12529821 |
| 117 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10583693 |
| 118 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.08861501 |
| 119 | cellular response to interleukin-4 (GO:0071353) | 3.07802724 |
| 120 | positive regulation of cell killing (GO:0031343) | 3.05378561 |
| 121 | cellular defense response (GO:0006968) | 3.04379212 |
| 122 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03285946 |
| 123 | T cell apoptotic process (GO:0070231) | 3.02560705 |
| 124 | positive regulation of interleukin-1 production (GO:0032732) | 3.02182288 |
| 125 | negative regulation of viral process (GO:0048525) | 3.02103811 |
| 126 | regulation of natural killer cell differentiation (GO:0032823) | 3.01076857 |
| 127 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.00799004 |
| 128 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00192869 |
| 129 | regulation of B cell mediated immunity (GO:0002712) | 2.97944392 |
| 130 | regulation of immunoglobulin production (GO:0002637) | 2.96985502 |
| 131 | hypothalamus development (GO:0021854) | 2.96205094 |
| 132 | regulation of T cell activation (GO:0050863) | 2.93831952 |
| 133 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92723068 |
| 134 | regulation of T cell cytokine production (GO:0002724) | 2.91008344 |
| 135 | T cell homeostasis (GO:0043029) | 2.89992004 |
| 136 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.88668881 |
| 137 | detection of other organism (GO:0098543) | 2.87460137 |
| 138 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.86190104 |
| 139 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.84932228 |
| 140 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.84932228 |
| 141 | positive regulation of immunoglobulin production (GO:0002639) | 2.84872148 |
| 142 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.84573152 |
| 143 | regulation of lymphocyte differentiation (GO:0045619) | 2.84015065 |
| 144 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82764340 |
| 145 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82764340 |
| 146 | regulation of B cell differentiation (GO:0045577) | 2.82219552 |
| 147 | response to interleukin-4 (GO:0070670) | 2.80517777 |
| 148 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.80027309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.12823335 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.04218078 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.02347332 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.95300538 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.93326733 |
| 6 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.86676666 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.35706446 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.28025536 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11937275 |
| 10 | UTX_26944678_Chip-Seq_JUKART_Human | 3.10976455 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.08743757 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.08717946 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.08166229 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 3.06391619 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.92336207 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86599011 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.83046623 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74214018 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51970414 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.39449880 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39323567 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.38614810 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.27914685 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 2.17821350 |
| 25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.14597873 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.05042391 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03305579 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.2713836 |
| 29 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99167886 |
| 30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.97504502 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91497908 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90222388 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89959204 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88903897 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79145735 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73068033 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71234001 |
| 38 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.67105517 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64729339 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61611034 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59940849 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56030585 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.51493402 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47794227 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.46560423 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45266361 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44244675 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41511287 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.41426886 |
| 50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.38242482 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38003428 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36618596 |
| 53 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32315875 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32065262 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31658248 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28875503 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25819401 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24229067 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23018275 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22963773 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20758167 |
| 62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19909454 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19366599 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17671125 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17548306 |
| 66 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.16964586 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15971796 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13418195 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11754740 |
| 70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.10874846 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10672035 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08522581 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08116609 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07127518 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06619157 |
| 76 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06288221 |
| 77 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05545198 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01593373 |
| 79 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.00533184 |
| 80 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.00126654 |
| 81 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98050819 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97290878 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96694363 |
| 84 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94855212 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93873116 |
| 86 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93657634 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91008423 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90347803 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89559569 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87838762 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86998084 |
| 92 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86771109 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86612176 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86609732 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85986149 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83863698 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 0.83583332 |
| 98 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83297722 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.82474138 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81631291 |
| 101 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81428266 |
| 102 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81195586 |
| 103 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79932901 |
| 104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79289181 |
| 105 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.79180519 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79134787 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78668533 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.78360796 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76974088 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76564198 |
| 111 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.76476441 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.76264839 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76072953 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75570795 |
| 115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74780864 |
| 116 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.74612808 |
| 117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74517025 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74344639 |
| 119 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.73801160 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72729919 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72309149 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71613987 |
| 123 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.70148703 |
| 124 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.69224996 |
| 125 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68327724 |
| 126 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.66670716 |
| 127 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66281098 |
| 128 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.64697381 |
| 129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63709494 |
| 130 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.63634820 |
| 131 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.62829248 |
| 132 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.62193893 |
| 133 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.62034173 |
| 134 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58317388 |
| 135 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56771003 |
| 136 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.55625599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.86369679 |
| 2 | MP0005671_abnormal_response_to | 3.48856870 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 3.26838464 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.99661464 |
| 5 | MP0003724_increased_susceptibility_to | 2.95938923 |
| 6 | MP0000685_abnormal_immune_system | 2.84033688 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.73529592 |
| 8 | MP0001800_abnormal_humoral_immune | 2.69914595 |
| 9 | MP0003436_decreased_susceptibility_to | 2.66729956 |
| 10 | MP0000703_abnormal_thymus_morphology | 2.62759690 |
| 11 | MP0004947_skin_inflammation | 2.57906597 |
| 12 | MP0003866_abnormal_defecation | 2.57288932 |
| 13 | MP0001727_abnormal_embryo_implantation | 2.55020302 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.49772800 |
| 15 | MP0005387_immune_system_phenotype | 2.42918036 |
| 16 | MP0001790_abnormal_immune_system | 2.42918036 |
| 17 | MP0002398_abnormal_bone_marrow | 2.42201980 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.38079128 |
| 19 | MP0002723_abnormal_immune_serum | 2.37086358 |
| 20 | MP0004381_abnormal_hair_follicle | 2.36054868 |
| 21 | MP0001819_abnormal_immune_cell | 2.35421969 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.30181253 |
| 23 | MP0002006_tumorigenesis | 2.22566227 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 2.21096443 |
| 25 | MP0000383_abnormal_hair_follicle | 2.20468097 |
| 26 | MP0002722_abnormal_immune_system | 2.19344765 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.14857359 |
| 28 | MP0002405_respiratory_system_inflammati | 2.08625554 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.08619740 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 2.08430192 |
| 31 | MP0000716_abnormal_immune_system | 2.05457233 |
| 32 | MP0003303_peritoneal_inflammation | 2.02609224 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 2.01604112 |
| 34 | MP0009785_altered_susceptibility_to | 2.01302675 |
| 35 | MP0003300_gastrointestinal_ulcer | 2.01139792 |
| 36 | MP0005025_abnormal_response_to | 2.00906064 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.95123939 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.90126844 |
| 39 | MP0006082_CNS_inflammation | 1.88216331 |
| 40 | MP0002933_joint_inflammation | 1.81525334 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.74909615 |
| 42 | MP0010307_abnormal_tumor_latency | 1.74863707 |
| 43 | MP0001873_stomach_inflammation | 1.67279047 |
| 44 | MP0005310_abnormal_salivary_gland | 1.65907154 |
| 45 | MP0002429_abnormal_blood_cell | 1.63390507 |
| 46 | MP0005451_abnormal_body_composition | 1.63267299 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.54783517 |
| 48 | MP0002796_impaired_skin_barrier | 1.47704574 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.44826742 |
| 50 | MP0004510_myositis | 1.44579524 |
| 51 | MP0001191_abnormal_skin_condition | 1.44341428 |
| 52 | MP0003787_abnormal_imprinting | 1.44251156 |
| 53 | MP0010678_abnormal_skin_adnexa | 1.42712289 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.39237483 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.37732034 |
| 56 | MP0001853_heart_inflammation | 1.35188702 |
| 57 | MP0001216_abnormal_epidermal_layer | 1.34790281 |
| 58 | MP0002419_abnormal_innate_immunity | 1.33400445 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.29389763 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.25971458 |
| 61 | MP0002822_catalepsy | 1.25027035 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.24676769 |
| 63 | MP0005023_abnormal_wound_healing | 1.23191037 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.21486997 |
| 65 | MP0002163_abnormal_gland_morphology | 1.20523047 |
| 66 | MP0000858_altered_metastatic_potential | 1.19566405 |
| 67 | MP0005501_abnormal_skin_physiology | 1.18651999 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.15805772 |
| 69 | MP0001243_abnormal_dermal_layer | 1.15373057 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.15159479 |
| 71 | MP0000377_abnormal_hair_follicle | 1.14481620 |
| 72 | MP0006054_spinal_hemorrhage | 1.10216752 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.05625507 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.03843555 |
| 75 | MP0002009_preneoplasia | 1.01807916 |
| 76 | MP0009764_decreased_sensitivity_to | 1.00610171 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.97985506 |
| 78 | MP0002090_abnormal_vision | 0.94660697 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.92468684 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.91658940 |
| 81 | MP0000627_abnormal_mammary_gland | 0.91065449 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.90938346 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.90052381 |
| 84 | MP0008260_abnormal_autophagy | 0.89713099 |
| 85 | MP0000647_abnormal_sebaceous_gland | 0.88971015 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.88548275 |
| 87 | MP0001851_eye_inflammation | 0.87875583 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.87027430 |
| 89 | MP0000490_abnormal_crypts_of | 0.86831832 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.86004994 |
| 91 | MP0002132_abnormal_respiratory_system | 0.82377077 |
| 92 | MP0003786_premature_aging | 0.77511456 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.76181688 |
| 94 | MP0003448_altered_tumor_morphology | 0.75566553 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.75249952 |
| 96 | MP0003075_altered_response_to | 0.73255706 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.71830550 |
| 98 | MP0003941_abnormal_skin_development | 0.71665780 |
| 99 | MP0001958_emphysema | 0.70266221 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.70084298 |
| 101 | MP0000367_abnormal_coat/_hair | 0.69319516 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.67856738 |
| 103 | MP0003091_abnormal_cell_migration | 0.67664762 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.66816037 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65023471 |
| 106 | MP0002095_abnormal_skin_pigmentation | 0.64736434 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.63186300 |
| 108 | MP0002060_abnormal_skin_morphology | 0.62078301 |
| 109 | MP0010771_integument_phenotype | 0.58024108 |
| 110 | MP0010352_gastrointestinal_tract_polyps | 0.57748050 |
| 111 | MP0009763_increased_sensitivity_to | 0.56750986 |
| 112 | MP0005390_skeleton_phenotype | 0.56731202 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.56500144 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.56323075 |
| 115 | MP0005166_decreased_susceptibility_to | 0.55616823 |
| 116 | MP0003795_abnormal_bone_structure | 0.54541975 |
| 117 | MP0002098_abnormal_vibrissa_morphology | 0.54333739 |
| 118 | MP0000477_abnormal_intestine_morphology | 0.54102060 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53889908 |
| 120 | MP0001340_abnormal_eyelid_morphology | 0.53714292 |
| 121 | MP0001881_abnormal_mammary_gland | 0.53597435 |
| 122 | MP0008469_abnormal_protein_level | 0.53575163 |
| 123 | MP0008569_lethality_at_weaning | 0.53103674 |
| 124 | MP0009931_abnormal_skin_appearance | 0.52844120 |
| 125 | MP0001188_hyperpigmentation | 0.51418239 |
| 126 | MP0001919_abnormal_reproductive_system | 0.50523772 |
| 127 | MP0000604_amyloidosis | 0.49598172 |
| 128 | MP0003045_fibrosis | 0.48894708 |
| 129 | MP0000920_abnormal_myelination | 0.47257461 |
| 130 | MP0008873_increased_physiological_sensi | 0.45129687 |
| 131 | MP0008877_abnormal_DNA_methylation | 0.44229818 |
| 132 | MP0003329_amyloid_beta_deposits | 0.43226430 |
| 133 | MP0000371_diluted_coat_color | 0.43183193 |
| 134 | MP0002168_other_aberrant_phenotype | 0.42898007 |
| 135 | MP0008874_decreased_physiological_sensi | 0.42296994 |
| 136 | MP0004742_abnormal_vestibular_system | 0.39864895 |
| 137 | MP0001663_abnormal_digestive_system | 0.39683717 |
| 138 | MP0002083_premature_death | 0.37154953 |
| 139 | MP0000249_abnormal_blood_vessel | 0.36616152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.08920847 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.75431981 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 5.84024844 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 5.70132739 |
| 5 | Combined immunodeficiency (HP:0005387) | 5.54572823 |
| 6 | Stomatitis (HP:0010280) | 5.14670070 |
| 7 | Abnormality of T cells (HP:0002843) | 4.75777291 |
| 8 | Congenital stationary night blindness (HP:0007642) | 4.69875710 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.61219956 |
| 10 | Abnormality of the fingertips (HP:0001211) | 4.53201744 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.52528232 |
| 12 | Nasal polyposis (HP:0100582) | 4.33298405 |
| 13 | Recurrent bronchitis (HP:0002837) | 4.31646292 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.28824335 |
| 15 | Autoimmune hemolytic anemia (HP:0001890) | 4.28662661 |
| 16 | IgM deficiency (HP:0002850) | 4.13556078 |
| 17 | Recurrent viral infections (HP:0004429) | 3.99492849 |
| 18 | Aplastic anemia (HP:0001915) | 3.93388366 |
| 19 | Pustule (HP:0200039) | 3.78659948 |
| 20 | Abnormality of oral frenula (HP:0000190) | 3.70198477 |
| 21 | Eosinophilia (HP:0001880) | 3.67726907 |
| 22 | Chronic otitis media (HP:0000389) | 3.62126898 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.56921067 |
| 24 | Obstructive lung disease (HP:0006536) | 3.56921067 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.56239910 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 3.53602382 |
| 27 | Hypoplasia of the thymus (HP:0000778) | 3.51940487 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.48184657 |
| 29 | Abnormal sex determination (HP:0012244) | 3.48156793 |
| 30 | Sex reversal (HP:0012245) | 3.48156793 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46905508 |
| 32 | Abnormality of eosinophils (HP:0001879) | 3.40286527 |
| 33 | Colitis (HP:0002583) | 3.37596453 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.37036880 |
| 35 | Chronic diarrhea (HP:0002028) | 3.32713484 |
| 36 | Inflammation of the large intestine (HP:0002037) | 3.32030827 |
| 37 | IgG deficiency (HP:0004315) | 3.31494260 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.27237588 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.25346340 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 3.25346340 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 3.19634626 |
| 42 | Lymphopenia (HP:0001888) | 3.11737078 |
| 43 | Orchitis (HP:0100796) | 3.08447682 |
| 44 | Severe Myopia (HP:0011003) | 3.03340751 |
| 45 | IgA deficiency (HP:0002720) | 3.03302481 |
| 46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.01600085 |
| 47 | Granulocytopenia (HP:0001913) | 2.99142831 |
| 48 | Joint swelling (HP:0001386) | 2.98189442 |
| 49 | Optic neuritis (HP:0100653) | 2.96542453 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.96542453 |
| 51 | Encephalitis (HP:0002383) | 2.93729166 |
| 52 | Periodontitis (HP:0000704) | 2.92961765 |
| 53 | Leukocytosis (HP:0001974) | 2.91559769 |
| 54 | Abnormality of B cell number (HP:0010975) | 2.91425735 |
| 55 | B lymphocytopenia (HP:0010976) | 2.91425735 |
| 56 | Recurrent sinusitis (HP:0011108) | 2.91315739 |
| 57 | Increased IgE level (HP:0003212) | 2.87993596 |
| 58 | Hemoptysis (HP:0002105) | 2.85666416 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.85176327 |
| 60 | Agammaglobulinemia (HP:0004432) | 2.79251549 |
| 61 | Abnormality of the gastric mucosa (HP:0004295) | 2.70022996 |
| 62 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.68726506 |
| 63 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.68726506 |
| 64 | Upper limb muscle weakness (HP:0003484) | 2.66250703 |
| 65 | Prostate neoplasm (HP:0100787) | 2.62762229 |
| 66 | Abnormality of male internal genitalia (HP:0000022) | 2.50371136 |
| 67 | Gangrene (HP:0100758) | 2.46458639 |
| 68 | Bronchitis (HP:0012387) | 2.44970627 |
| 69 | Hypoproteinemia (HP:0003075) | 2.43987870 |
| 70 | Abnormality of the prostate (HP:0008775) | 2.43761078 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.42585074 |
| 72 | Acute hepatic failure (HP:0006554) | 2.41987721 |
| 73 | Increased density of long bones (HP:0006392) | 2.41579037 |
| 74 | Thyroiditis (HP:0100646) | 2.41547762 |
| 75 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.41488347 |
| 76 | Villous atrophy (HP:0011473) | 2.41488347 |
| 77 | Increased IgM level (HP:0003496) | 2.41464213 |
| 78 | Episodic fever (HP:0001954) | 2.39050658 |
| 79 | Pulmonary embolism (HP:0002204) | 2.36644854 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.34852169 |
| 81 | Arterial thrombosis (HP:0004420) | 2.30499934 |
| 82 | Anorexia (HP:0002039) | 2.28175735 |
| 83 | Recurrent otitis media (HP:0000403) | 2.24679850 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.24650064 |
| 85 | Pulmonary fibrosis (HP:0002206) | 2.23871950 |
| 86 | Emphysema (HP:0002097) | 2.22901178 |
| 87 | Metaphyseal dysplasia (HP:0100255) | 2.22843973 |
| 88 | Spondylolisthesis (HP:0003302) | 2.22789810 |
| 89 | Gingivitis (HP:0000230) | 2.22677636 |
| 90 | Chronic sinusitis (HP:0011109) | 2.20103487 |
| 91 | Premature loss of primary teeth (HP:0006323) | 2.19346541 |
| 92 | Verrucae (HP:0200043) | 2.19207446 |
| 93 | Papilloma (HP:0012740) | 2.19207446 |
| 94 | Polyneuropathy (HP:0001271) | 2.17760105 |
| 95 | Ureteral obstruction (HP:0006000) | 2.17125603 |
| 96 | Keratoconjunctivitis sicca (HP:0001097) | 2.15356676 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.11830262 |
| 98 | Lymphoma (HP:0002665) | 2.11505068 |
| 99 | Basal cell carcinoma (HP:0002671) | 2.11499937 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 2.09526899 |
| 101 | Aortic aneurysm (HP:0004942) | 2.05156997 |
| 102 | Distal lower limb amyotrophy (HP:0008944) | 2.03244462 |
| 103 | Abnormality of binocular vision (HP:0011514) | 2.01496023 |
| 104 | Diplopia (HP:0000651) | 2.01496023 |
| 105 | Anhidrosis (HP:0000970) | 2.00971857 |
| 106 | Meningitis (HP:0001287) | 2.00913431 |
| 107 | Hypercortisolism (HP:0001578) | 2.00275527 |
| 108 | Vasculitis (HP:0002633) | 1.99788709 |
| 109 | Erythema (HP:0010783) | 1.97871784 |
| 110 | Skin rash (HP:0000988) | 1.97482666 |
| 111 | Microretrognathia (HP:0000308) | 1.95993454 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95907441 |
| 113 | Progressive inability to walk (HP:0002505) | 1.95418780 |
| 114 | Keratoconjunctivitis (HP:0001096) | 1.95106318 |
| 115 | Gastrointestinal infarctions (HP:0005244) | 1.94795829 |
| 116 | Alveolar cell carcinoma (HP:0006519) | 1.94621899 |
| 117 | Recurrent skin infections (HP:0001581) | 1.94477225 |
| 118 | Amaurosis fugax (HP:0100576) | 1.93976428 |
| 119 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93695527 |
| 120 | Hypochromic anemia (HP:0001931) | 1.92851940 |
| 121 | Testicular neoplasm (HP:0010788) | 1.91893930 |
| 122 | Recurrent abscess formation (HP:0002722) | 1.91414493 |
| 123 | Bifid scrotum (HP:0000048) | 1.89668242 |
| 124 | Glomerulopathy (HP:0100820) | 1.89620535 |
| 125 | Spontaneous hematomas (HP:0007420) | 1.87728203 |
| 126 | Thrombocytosis (HP:0001894) | 1.87063026 |
| 127 | Increased intramyocellular lipid droplets (HP:0012240) | 1.84686292 |
| 128 | Bronchiectasis (HP:0002110) | 1.84362771 |
| 129 | Zonular cataract (HP:0010920) | 1.84052270 |
| 130 | Epistaxis (HP:0000421) | 1.83385863 |
| 131 | Poor speech (HP:0002465) | 1.83255673 |
| 132 | Hepatitis (HP:0012115) | 1.82797540 |
| 133 | Urticaria (HP:0001025) | 1.82692027 |
| 134 | Protrusio acetabuli (HP:0003179) | 1.79903967 |
| 135 | Papilledema (HP:0001085) | 1.79492361 |
| 136 | Abnormality of nail color (HP:0100643) | 1.78735920 |
| 137 | Gingival bleeding (HP:0000225) | 1.76978190 |
| 138 | Increased mean platelet volume (HP:0011877) | 1.76477487 |
| 139 | Keratitis (HP:0000491) | 1.75514125 |
| 140 | Gastrointestinal stroma tumor (HP:0100723) | 1.74561545 |
| 141 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.72465406 |
| 142 | Dilatation of the ascending aorta (HP:0005111) | 1.71435302 |
| 143 | Woolly hair (HP:0002224) | 1.70828077 |
| 144 | Prolonged bleeding time (HP:0003010) | 1.70434732 |
| 145 | Myositis (HP:0100614) | 1.68748614 |
| 146 | Stridor (HP:0010307) | 1.57014721 |
| 147 | Chest pain (HP:0100749) | 1.56918663 |
| 148 | Ureteral stenosis (HP:0000071) | 1.55887293 |
| 149 | Onion bulb formation (HP:0003383) | 1.53353048 |
| 150 | Bicuspid aortic valve (HP:0001647) | 1.53283657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.11182337 |
| 2 | TXK | 4.89008504 |
| 3 | EEF2K | 4.18718579 |
| 4 | ZAP70 | 3.62465937 |
| 5 | PIK3CA | 3.08395865 |
| 6 | ITK | 2.85666681 |
| 7 | FGFR4 | 2.76320360 |
| 8 | JAK3 | 2.61522644 |
| 9 | ALK | 2.56719264 |
| 10 | STK10 | 2.53932322 |
| 11 | DMPK | 2.31622315 |
| 12 | GRK6 | 2.13363847 |
| 13 | NLK | 2.11521505 |
| 14 | RIPK4 | 2.07668199 |
| 15 | HCK | 1.97339249 |
| 16 | IKBKE | 1.94778100 |
| 17 | TYK2 | 1.89567880 |
| 18 | LCK | 1.86566396 |
| 19 | NME2 | 1.71882165 |
| 20 | MAP3K14 | 1.71693058 |
| 21 | MST4 | 1.67548862 |
| 22 | CSK | 1.65013048 |
| 23 | SYK | 1.60234729 |
| 24 | EIF2AK3 | 1.59301249 |
| 25 | PRKCH | 1.58947948 |
| 26 | FGFR3 | 1.55296621 |
| 27 | JAK1 | 1.54885626 |
| 28 | MAP3K10 | 1.43915511 |
| 29 | TEC | 1.42543502 |
| 30 | AKT3 | 1.31716213 |
| 31 | EIF2AK1 | 1.25501788 |
| 32 | MAP3K13 | 1.23744773 |
| 33 | TAOK1 | 1.23139491 |
| 34 | FES | 1.22915029 |
| 35 | GRK1 | 1.21353637 |
| 36 | KDR | 1.21136527 |
| 37 | SIK3 | 1.19079103 |
| 38 | TGFBR1 | 1.18369424 |
| 39 | PRKCQ | 1.16679087 |
| 40 | RPS6KB2 | 1.14787654 |
| 41 | MAP3K7 | 1.11494650 |
| 42 | PKN2 | 1.11373262 |
| 43 | MAP3K12 | 1.11053466 |
| 44 | EPHB2 | 1.10194900 |
| 45 | CAMKK2 | 1.09922653 |
| 46 | BRD4 | 1.03696338 |
| 47 | LRRK2 | 1.02295628 |
| 48 | IRAK4 | 1.01853508 |
| 49 | IKBKB | 0.96383540 |
| 50 | NUAK1 | 0.94882982 |
| 51 | TNK2 | 0.93606891 |
| 52 | TAOK3 | 0.93141566 |
| 53 | MAPKAPK3 | 0.92040278 |
| 54 | RPS6KA4 | 0.90517968 |
| 55 | PASK | 0.90286846 |
| 56 | MAP3K11 | 0.86679569 |
| 57 | MAP4K2 | 0.85548561 |
| 58 | TBK1 | 0.85024641 |
| 59 | PRKD3 | 0.83238025 |
| 60 | CAMKK1 | 0.82023183 |
| 61 | BTK | 0.80687618 |
| 62 | CHUK | 0.80629304 |
| 63 | TTN | 0.79225756 |
| 64 | MARK2 | 0.76240491 |
| 65 | EPHB1 | 0.76202936 |
| 66 | BCR | 0.76039000 |
| 67 | TRIB3 | 0.75552828 |
| 68 | CDK4 | 0.75273129 |
| 69 | CSF1R | 0.72368897 |
| 70 | EPHA3 | 0.71740170 |
| 71 | TESK2 | 0.71159546 |
| 72 | GRK7 | 0.70350748 |
| 73 | BMPR2 | 0.69636303 |
| 74 | TRPM7 | 0.69430171 |
| 75 | HIPK2 | 0.68914665 |
| 76 | JAK2 | 0.68306240 |
| 77 | FGR | 0.68078697 |
| 78 | LYN | 0.66743745 |
| 79 | TLK1 | 0.63286720 |
| 80 | PIM1 | 0.61711585 |
| 81 | CDK12 | 0.60816898 |
| 82 | VRK2 | 0.58999650 |
| 83 | CDK6 | 0.57360487 |
| 84 | PDGFRB | 0.57188380 |
| 85 | MATK | 0.57102032 |
| 86 | ROCK2 | 0.57044325 |
| 87 | INSR | 0.54569922 |
| 88 | PRPF4B | 0.51916080 |
| 89 | FYN | 0.51901035 |
| 90 | MAPK7 | 0.50645213 |
| 91 | BLK | 0.50633117 |
| 92 | MARK3 | 0.50527039 |
| 93 | TYRO3 | 0.49727186 |
| 94 | ADRBK2 | 0.49325913 |
| 95 | BCKDK | 0.48992879 |
| 96 | FGFR1 | 0.48885500 |
| 97 | KIT | 0.48370471 |
| 98 | PDK1 | 0.46427365 |
| 99 | PRKD2 | 0.46328873 |
| 100 | MAPK12 | 0.45661772 |
| 101 | DAPK1 | 0.44725282 |
| 102 | IGF1R | 0.42887214 |
| 103 | RET | 0.42544069 |
| 104 | RPS6KA1 | 0.42122338 |
| 105 | RPS6KA5 | 0.41961790 |
| 106 | PAK2 | 0.41347395 |
| 107 | CDK9 | 0.40886228 |
| 108 | MAP3K1 | 0.40170627 |
| 109 | PRKCD | 0.40003292 |
| 110 | PIM2 | 0.39702312 |
| 111 | MAPK11 | 0.39219322 |
| 112 | MAP3K8 | 0.38372054 |
| 113 | MAP2K6 | 0.38112648 |
| 114 | SGK2 | 0.37010765 |
| 115 | IRAK1 | 0.36361085 |
| 116 | MAPKAPK2 | 0.35703229 |
| 117 | SGK3 | 0.35345766 |
| 118 | MAPK4 | 0.35218828 |
| 119 | NTRK2 | 0.34337890 |
| 120 | ERN1 | 0.33877003 |
| 121 | SIK1 | 0.33797453 |
| 122 | PRKD1 | 0.33397916 |
| 123 | EGFR | 0.33219068 |
| 124 | PRKCB | 0.32415999 |
| 125 | RPS6KA2 | 0.32320391 |
| 126 | CLK1 | 0.32182750 |
| 127 | CSNK1D | 0.31911472 |
| 128 | STK11 | 0.30993764 |
| 129 | SIK2 | 0.30674920 |
| 130 | RPS6KA6 | 0.30321988 |
| 131 | FGFR2 | 0.29595008 |
| 132 | MAPK15 | 0.27991944 |
| 133 | TGFBR2 | 0.27035541 |
| 134 | TSSK6 | 0.26615672 |
| 135 | VRK1 | 0.25433786 |
| 136 | MAP3K5 | 0.24017506 |
| 137 | FRK | 0.23214076 |
| 138 | SMG1 | 0.20755808 |
| 139 | PAK1 | 0.20045654 |
| 140 | CDK8 | 0.17840793 |
| 141 | DAPK2 | 0.17786166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.42917942 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.36056085 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.97330320 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.88570096 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78183916 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.66693772 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.35640389 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17914053 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10844568 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04025175 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86517685 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82204286 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78563424 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.77028800 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75659868 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.68542874 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.64264955 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.63663998 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61706049 |
| 20 | HTLV-I infection_Homo sapiens_hsa05166 | 1.56726843 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47956219 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.46555869 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45570982 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44029310 |
| 25 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.39610014 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35449589 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30825724 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.30722777 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27380420 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22748892 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19670132 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.12643696 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11554940 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11383833 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10905002 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08633413 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07559120 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05620995 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04846567 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03972682 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02566149 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02426939 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02357338 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.00021661 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.99511007 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95681033 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95175475 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.94837154 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93060723 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88018708 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.87419562 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.86050494 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81843322 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79069008 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76618395 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.76531119 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.76481953 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.75979956 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74265917 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72286251 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71808762 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71580956 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68442110 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67191696 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63736093 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63710876 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62971263 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62950079 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61170173 |
| 70 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60890450 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.60153247 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60025408 |
| 73 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59024682 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58835881 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.58085432 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57869697 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55628647 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55628467 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55543797 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.50571497 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50113333 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50100200 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.49984011 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49917223 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49561781 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.49069005 |
| 87 | Protein export_Homo sapiens_hsa03060 | 0.46290965 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46033706 |
| 89 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44687085 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44660853 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42368838 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.40937386 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40696657 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38135813 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37580714 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.36858510 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35948813 |
| 98 | Spliceosome_Homo sapiens_hsa03040 | 0.35678465 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34988071 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33883769 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.32558576 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.32059472 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31774852 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.30423574 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30313889 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.30191426 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30113892 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29844047 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29747807 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29647176 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29249981 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28707907 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.28643603 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27152780 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26177772 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22660150 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22003054 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21417528 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17625015 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17545830 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.16306057 |
| 122 | RNA degradation_Homo sapiens_hsa03018 | 0.15976543 |
| 123 | Basal transcription factors_Homo sapiens_hsa03022 | 0.14327505 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.11748639 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09693089 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.08714340 |
| 127 | Long-term potentiation_Homo sapiens_hsa04720 | 0.06090006 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.02868013 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.01009675 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00905488 |
| 131 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.00329715 |

